west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "视网膜疾病/药物疗法" 5 results
  • 右侧颈内动脉夹层导致眼缺血综合征一例

    Release date:2016-09-02 05:43 Export PDF Favorites Scan
  • Intravitreal injection of ranibizumab for retinal angiomatous proliferation

    ObjectiveTo observe the efficacy of intravitreal injection of ranibizumab (IVR) for retinal angiomatous proliferation (RAP). MethodsEleven patients (14 eyes) with RAP were enrolled in this retrospective clinical study. The best-corrected visual acuity (BCVA), central retinal thickness (CRT), and maximum retinal thickness (MRT) were detected by examination of visual acuity and optical coherence tomography (OCT). The average BCVA was 0.17±0.21, CRT was (382.71±219.07) μm, MRT was (746.36±268.29) μm. All eyes received 0.5 mg (0.05 ml) ranibizumab injection. Follow-up visits were performed monthly after injection. The mean follow-up time was (15.38±13.64) month. Injections were repeated if the eyes with retinal edema. The mean number of repetitive IVR was (3.7±1.0) times/eye (from 1 to 10 times). Changes in BCVA, CRT, MRT and complications were observed at the last follow up. ResultsAt the last follow-up, the mean BCVA was 0.28±0.26 (from 0.01 to 1.0). Of 14 eyes, visual acuity improved in 11 eyes, not changed in 2 eyes and decreased in 1 eye. The difference of BCVA was significant between before and after the treatment (t=3.167,P=0.007). The mean CRT was (166.14±52.79) μm, which was less than that of pre-treatment values (t=3.737,P=0.002). The mean MRT was (360.43±102.19) μm, which was less than that of pre-treatment values (t=6.106,P=0.000). No ocular or systemic adverse effects occurred. ConclusionIVR is an efficient and safe treatment for RAP, with visual acuity improvement, decrease of CRT and MRT.

    Release date: Export PDF Favorites Scan
  • 玻璃体腔注射抗病毒药物治疗病毒性视网膜疾病的研究进展

    抗病毒药物的玻璃体腔注射能够很快在局部达到有效药物浓度,减少药物对全身其他脏器的非特异性损伤,从而高效治疗病毒性视网膜疾病。急性视网膜坏死综合征、进行性外层视网膜坏死、巨细胞病毒性视网膜炎等疾病应用玻璃体腔注射抗病毒药物治疗可取得较好的临床效果。玻璃体腔注射抗病毒药物可以作为病毒性视网膜疾病治疗的一个重要手段而在其治疗过程中首先使用。如何根据药物特性减少其注射频率、降低药物以及注射相关的并发症,提高其对病毒性视网膜疾病的治愈率,仍是值得进一步研究的问题。

    Release date: Export PDF Favorites Scan
  • 抗血管内皮生长因子药物治疗皮肤色素失禁症相关性视网膜病变一例

    Release date: Export PDF Favorites Scan
  • 雷珠单抗联合视网膜冷冻经巩膜外脉络膜上腔放液治疗双眼Coats病一例

    Release date: Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content